A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial
Titel:
A randomised phase II trial of docetaxel versus docetaxel plus carboplatin in patients with castration-resistant prostate cancer who have progressed after response to prior docetaxel chemotherapy: The RECARDO trial
Auteur:
Bouman-Wammes, Esther W. van den Berg, H. Pieter de Munck, Linda Beeker, Aart Smorenburg, Carolien H. Vervenne, Walter L. Coenen, Juleon L.L.M. Verheul, Henk M.W. Gerritsen, Winald R. Van den Eertwegh, Alfons J.M.